Skip to main content

New Products: Jun 17, 2011

Premium

NanoInk has launched its new NanoArray Assay System for creating nanoscale protein arrays.

The system, which is based on NanoInk's tip-based Dip Pen Nanolithography technology, enables the creation of reproducible protein arrays over millimeter areas with nanometer precision. The arrays can be fluorescently imaged at high resolution and can generate data from samples as small as two microliters, the company said. The device is compatible with NanoInk's line of proteomic assays.


Integromics has released its OmicsHub Proteomics 2.0 software for data management and analysis in mass spec labs and core facilities.
The package is a web-based, multi-user platform designed to perform automatic tasks such as batch searches of multiple protein databases, pathway integrations, and functional annotations in order to address human error and time and data management issues, the company said.


NextGen Sciences has launched its plasmamultiplesclerosis15 multiplex protein assay for the discovery and quantification of protein biomarkers linked to multiple sclerosis.

The assays use multiple-reaction monitoring mass spectrometry to simultaneously measure proteins in plasma samples.


Avantra Biosciences has launched its Rapid Assay Prototyping Service, providing researchers and clinicians with custom, disease-specific biomarker assays.

The assays are developed on Avantra's QPDx BioChip platform, using pre-validated antibody pairs or customers' own immunoassay reagents, the company said.


ProImmune this week introduced its new ProArray Ultra, a protein and peptide microarray platform designed for high-throughput investigations of immune responses.

The platform allows for the analysis of more than 30,000 peptides or proteins at once and can work with as little as 1 microliter of sample, the company said.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.